Categories
C-IP2 News Communications Progress Reports

CPIP Second Quarter Progress Report (March-May 2021)

Sean O'ConnorGreetings from CPIP Executive Director Sean O’Connor

We are cautiously optimistic as locations around the globe move towards greater control of the COVID pandemic. With luck, diligence, and generosity by public and private sectors around the world, we can all strive for vaccines to be more widely accessible and a future in which we can see other in person again.

Our Second Quarter Progress Report for 2021 covers CPIP’s and our affiliates’ events, news, scholarship, and more from March through May of this year. Our team has just wrapped up the fourth iteration of the WIPO-U.S. Summer School on Intellectual Property at CPIP, and we’re looking forward to in-person and hybrid programming in the coming months––look for details in our future progress reports and communications. We also have an exciting new name announcement coming later this week, and we’re looking forward to seeing what the rest of the year brings. In the meantime, I’m pleased to present this report on CPIP’s output from the past few months.


CPIP Hosted & Co-Hosted Events

On Wednesday, March 3, Arlington Economic Development’s BizLaunch network co-hosted a public online event entitled “Mason Law Clinic @BizLaunch: Which Entity is Right for Your Startup?” with George Mason University Antonin Scalia Law School’s Innovation Law Clinic, which is led by CPIP Executive Director Sean O’Connor. The virtual clinic addressed entrepreneurship and which business entities might best fit a business’s needs and attract investment. The panelists were Kenneth Silverberg, Senior Counsel at Nixon Peabody, and third-year Scalia Law students Mitch Gibson and Rebecka Haynes. A video of the event is available on CPIP’s YouTube page.

Now in its seventh iteration, CPIP’s 2021-2022 Thomas Edison Innovation Law and Policy Fellowship had its first virtual meeting on Thursday, March 18, and Friday, March 19. The Edison Fellowship is a year-long non-resident fellowship program that brings together a group of scholars to develop research papers on intellectual property law and policy. The Edison Fellowship is one of the centerpieces of CPIP’s mission to promote a better academic discussion about intellectual property rights with substantial scholarship produced from rigorous research that examines the moral and economic value of innovation. This year’s topics include: the PTAB, patent disclosures and artificial intelligence, levels of licensing of SEPs, SEPs vs NEPs in litigation, drug repurposing and generics, regulatory exclusivities, copyright law, privacy law, and the right of publicity.

From April 15-16, CPIP hosted a virtual roundtable discussion on Copyright and the Constitution. This private, invitation-only roundtable explored current and historical topics in Copyright and the Constitution. Proposals to address challenges faced by authors and owners of copyrighted works are frequently met by claims from opponents that the proposals do not pass constitutional muster. Such allegations are typically baseless; however, they delay and increase the costs of pursuing legislative and other measures intended to protect and promote the creativity of authors. This roundtable investigated what has transpired in the courts and public discourse as well as how these precedents might inform current and future efforts to protect the interests of the creative community and ultimately the public.

On May 4 and as part of Arlington Forward’s 20:20 Series, CPIP co-hosted a virtual panelProtecting What You Build: Intellectual Property as the Entrepreneur’s Core Asset, with CPIP Directors Professor Sean O’Connor, Professor Sandra Aistars, and Joshua Kresh as the featured speakers. Great entrepreneurs execute on an innovative vision to improve the lives of others. Whether for profit or not for profit, the core of these ventures consists of particular solutions to tough problems. Such solutions in turn are combinations of information and practical methods, code or devices that are legally defined as intellectual property. Patents, copyrights, trade secrets and trademarks play different roles in defining the scope, title and rights to innovative solutions. This session guided attendees through these types of intellectual property and explained how experienced entrepreneurs rely on them to implement their visions. A video of the event is available on CPIP’s YouTube page.


News & Speaking Engagements

On Tuesday, March 30, the U.S. News & World Report Rankings came out, and CPIP is pleased to report that Scalia Law placed 41 overall and that the IP program went from 30 to 26. Also, the part-time law program at Scalia Law ranked No. 4 among public and private institutions.

Congratulations to all the Scalia Law students who graduated on May 15! This was a challenging year with unprecedented obstacles and we appreciate the students’ patience in adjusting to the online class format and doing their best. Well done and best of luck!

Further, CPIP would like to congratulate The Honorable Kimberly A. Moore, who became Chief Judge of the United States Court of Appeals for the Federal Circuit on May 22, 2021. She succeeded the Honorable Sharon Prost, who served as Chief Judge since May 31, 2014. Before joining the bench, Judge Moore was a faculty member of our George Mason University School of Law.

The Innovation Law Clinic, an affiliate of CPIP, was mentioned in the article “New pilot space debuts in Arlington” in Mason’s newsletter, The George, on May 27. The Clinic and other related innovation programs will temporarily be housed in a “showroom” location at Vernon Smith Hall until moving into the Mason Exchange building under construction here on the Arlington campus with a scheduled opening date of May 2025.

Sandra Aistars (CPIP Director of Copyright Research and Policy; Founding Director, Arts & Entertainment Advocacy Clinic; Clinical Professor of Law, George Mason University Antonin Scalia Law School)

    • Spoke at Scalia Law’s virtual Admissions Event on March 18
    • Along with filmmaker Lynn Hughes, was a featured speaker for an online clinic, “Copyright Law and the CASE Act,” on March 23. The event was organized under Prof. Aistars’ guidance by the Arts & Entertainment Advocacy Clinic at Antonin Scalia Law School and co-hosted with Washington Area Lawyers for the Arts (WALA). The clinic also conducted a live Q&A session for artists.
    • Spoke that same evening (March 23) on a virtual panel, “Representing Women: A Conversation on Representation for Artists and of Women in the Arts,” as part of the George Washington Law Association for Women’s March webinar series Nine: Portraits of Women in the Law
    • On April 6, moderated a virtual panel entitled “Artist Roundtable: Representing and Working with Artists in the Digital Age,” which was hosted by Scalia Law’s Arts & Entertainment Advocacy Clinic. The panel consisted of three creators on the forefront of art and creativity in the digital age: musician, singer, and songwriter David Lowery; film director, producer, and editorial photographer Stacey Marbrey; and author, communications professional, and copyright advocate David Newhoff. They spoke about their careers and what artists look for when partnering with legal counsel or other advocates, as well as issues that matter to artists and businesses in the arts today.
    • Spoke on the virtual panel “Platform Liability in the US and EU” during the 28th Annual Fordham IP Conference on April 9
    • Organized and signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • Moderated a virtual Federalist Society panel, “Courthouse Steps Decision Webinar: Google v. Oracle,” on April 16 (the podcast version is also available via the link)
    • Participated as a panelist during an IP law section discussion on Google v. Oracle hosted virtually by the American Bar Association on April 29
    • Participated in Scalia Law’s Law & Economics Center’s program Introduction to the Economics of Information, Privacy, and Data Security from May 19-23
    • Co-wrote, organized, and filed a May amicus brief, signed by IP scholars, stating that the Federal Circuit should reverse the Eastern District of Texas’ judgment in SAS Institute Inc. v. World Programming Ltd.: “The Court’s holding that Plaintiff’s works are uncopyrightable in their entirety was reached through a flawed examination, in the context of a novel proceeding, that is inconsistent with both the Copyright Act and applicable case law. If sustained, this approach would significantly undermine Congressional intent of promoting and rewarding copyright registration, and set the bar of establishing copyrightability so high that it would prejudice copyright owners not merely in the software sector, but across the full spectrum of creative works.” Students of the Arts & Entertainment Advocacy Clinic helped to research and prepare the brief; Robert W. Clarida (Partner, Reitler Kailas & Rosenblatt, LLC) served as counsel of record, and Steven M. Tepp (President & CEO, Sentinel Worldwide) provided valuable advice.

Jonathan Barnett (CPIP Senior Fellow for Innovation Policy & Senior Scholar; Torrey H. Webb Professor of Law, USC Gould School of Law)

Eric Claeys (CPIP Senior Scholar; Professor of Law, George Mason University Antonin Scalia Law School)

Devlin Hartline (Former Director of Communications, CPIP; Former Assistant Professor of Law, George Mason University Antonin Scalia Law)

    • Served as Presiding Officer on March 23, the first day of the virtual 16th Annual Advanced Patent Law Institute, and introduced Acting USPTO Director Drew Hirshfeld, among others. This event was co-sponsored by the University of Texas School of Law and the Antonin Scalia Law School and hosted by the USPTO.
    • Attended the University of Akron School of Law’s virtual 23rd Annual Symposium on Intellectual Property Law and Policy on March 25-26 and moderated the final panel, “The Latest Tools and Challenges for Copyright Enforcement,” on March 26
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • Along with other IP scholars, signed a May amicus brief stating that the Federal Circuit should reverse the Eastern District of Texas’ judgment in SAS Institute Inc. v. World Programming Ltd.
    • As of late May 2021, Devlin Hartline has left CPIP and George Mason University Antonin Scalia Law School. Devlin joined CPIP in May 2015 and, as a core member of the team, has contributed substantially to CPIP’s mission, events, programs, and scholarship––as well as team morale––over these past six years. As his teammates, we will miss working with him, and we want to thank him for all his contributions and dedicated work at CPIP. We also wish him the best as he joins the Hudson Institute this July. For now, you can find Devlin on Twitter @devlinhartline.

Christopher Holman (CPIP Senior Fellow for Life Sciences & Senior Scholar; Professor of Law, University of Missouri-Kansas City School of Law)

    • Participated as a Distinguished Senior Commentator in the first meeting of the 2021-2022 Thomas Edison Innovation Law and Policy Fellowship, held virtually March 18-19
    • With CPIP Executive Director Prof. Sean O’Connor, submitted written comments on April 5 to NIST on proposed changes to Bayh-Dole Regulations
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections

Joshua Kresh (CPIP Deputy Director)

    • Attended the 28th Annual Fordham IP Conference on April 8-9
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • Served as a coordinator for AIPLA’s 2021 Virtual Spring Meeting, which was held from May 10-14 (the event program can be viewed here)

Erika Lietzan (CPIP Senior Scholar; William H Pittman Professor of Law & Timothy J. Heinsz Professor of Law, University of Missouri School of Law)

Hina Mehta (CPIP Scholar; Director, Office of Technology Transfer, George Mason University)

    • Gave a webinar on Research Trends at George Mason University for University of Bahrain’s event UoB Research Nights held in mid-May

Sean M. O’Connor (CPIP Executive Director; Founding Director, Innovation Law Clinic; Professor of Law, George Mason University Antonin Scalia Law School)

    • Featured CLE speaker at Washington State Patent Lawyers Association’s event, “Bypassing Patents in the Pandemic? The Biden Administration Should Beware Revisionist Accounts of March-In Rights and Sec. 1498” on March 17
    • Spoke at Scalia Law’s virtual Admissions Event on March 18
    • Quoted in a March 29 article by FiercePharma, “Biden faces calls to break COVID-19 vaccine patents. Would that boost global supply?”
    • With CPIP Senior Scholar Prof. Chris Holman, submitted written comments on April 5 to NIST on proposed changes to Bayh-Dole Regulations
    • Featured CLE speaker at Patent and Trademark Office Society (PTOS) event “Bypassing Patents in the Pandemic? The Biden Administration Should Beware Revisionist Accounts of March-In Rights and Sec. 1498” held virtually on April 6
    • Spoke on the virtual panel “Copyright & Music” during the 28th Annual Fordham IP Conference on April 9
    • Spoke on the virtual panel “Intermediary Liability at the Application Layer and Beyond” at the Silicon Flatirons conference, Platform Policy for Networks, Infrastructure, and Applications, on April 14
    • Signed an April 14 “Open Letter by Academics in Favor of Direct EV Sales and Service” supporting direct-to-consumer sales by EV manufacturers such as Tesla (the accompanying letter by public interest organizations can be found here)
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • Spoke on the virtual panel “Google v. Oracle: An Initial Appraisal” hosted by Berkeley Center for Law and Technology on April 20
    • Participated in the U.S. Embassy Tokyo’s World IP Day virtual program on IP & SMEs: Taking your ideas to market, speaking on the panel entitled “Patents to Patients: The Role of Intellectual Property in Innovative Healthcare” on the evening of April 26 JST (Japanese-language video of event available here)

Kristen Jakobsen Osenga (CPIP Senior Scholar; Austin E. Owen Research Scholar and Professor of Law, University of Richmond School of Law)

    • Moderated a Federalist Society panel, “Courthouse Steps Oral Argument Webinar: United States v. Arthrex Inc.,” on March 1
    • Starting in March 2021, Prof. Osenga has taken over the chair of the Federalist Society Intellectual Property Group Executive Committee from Professor Mark Schultz.
    • Featured in a short video by the Federalist Society on “What is a Trademark? [Legal Terms]” on April 13
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • Spoke on the virtual panel on “The Common Purposes of Intellectual Property and Antitrust” with Ashley Baker and Seth Cooper and organized by the Committee for Justice on April 19 (Video of panel available here)
    • Mentioned in an April 28 Patently-O post, “The Public Private Nature of Patents,” by Dennis Crouch, as representing the appellant company Kannuu in Kannuu Pty Ltd. v. Samsung Electronics Co., Ltd.
    • Featured in the Gray Matters podcast on May 4 in the episode “Regulating Vaccines After COVID-19: A Conversation with Sam Kalabi and Kristen Osenga”
    • Featured in a video by University of Richmond School of Law, “The Synopsis: Patents on COVID Vaccines,” on May 12

Eric Priest (CPIP Senior Scholar; Associate Professor, University of Oregon School of Law)

    • Along with other IP scholars, signed a May amicus brief stating that the Federal Circuit should reverse the Eastern District of Texas’ judgment in SAS Institute Inc. v. World Programming Ltd.

Mark Schultz (CPIP Senior Scholar; Goodyear Tire & Rubber Company Chair in Intellectual Property Law, University of Akron School of Law; Director, Center for Intellectual Property Law and Technology)

    • Participated as a Distinguished Senior Commentator in the first meeting of the 2021-2022 Thomas Edison Innovation Law and Policy Fellowship, held virtually March 18-19
    • Was the drafting team co-lead on the 2021 Sedona Conference’s Framework for Analysis on Trade Secret Issues Across International Borders: Extraterritorial Reach, which has been published for public comment as of March
    • Held the University of Akron School of Law’s 23rd Annual Symposium on Intellectual Property Law and Policy virtually on March 25-26
    • Signed an April 15 letter to the Biden Administration urging opposition to the proposed WTO waiver to the TRIPS Agreement’s IP protections
    • On April 28, spoke on the World Intellectual Property Organization (WIPO) webinar “Closing the Gender Gap in Intellectual Property – Mapping and Addressing Barriers”
    • On April 29, spoke on the virtual panel “How Intellectual Property Has Played a Pivotal Role in the Global COVID-19 Response,” which hosted by the Information Technology & Innovation Foundation (ITIF)
    • On May 27, spoke on a webinar on “The Role of Intellectual Property during the pandemic,” held by the Institute for Prospective and Innovation in Health (INNOS) in Colombia. Both the writeup and a link to the webinar recording can be found on this page.
    • Along with other IP scholars, signed a May amicus brief stating that the Federal Circuit should reverse the Eastern District of Texas’ judgment in SAS Institute Inc. v. World Programming Ltd.

Ted Sichelman (CPIP Senior Scholar; Professor of Law, University of San Diego School of Law; Director, Center for Intellectual Property Law & Markets; Founder & Director, Center for Computation, Mathematics, and the Law; Founder & Director, Technology Entrepreneurship and Intellectual Property Clinic)

    • Mentioned in an April 28 Patently-O postThe Public Private Nature of Patents, written by Dennis Crouch, as representing the appellant company Kannuu in Kannuu Pty Ltd. v. Samsung Electronics Co., Ltd.

Scholarship & Other Writings

Alden Abbott, Kevin Madigan, Adam Mossoff, Kristen Osenga, and Zvi Rosen, Holding States Accountable for Copyright Piracy, Regulatory Transparency Project of the Federalist Society (May 13, 2021)

Jonathan M. Barnett, Antitrust Lessons from AT&T’s M&A Fiasco, Truth on the Market (May 24, 2021)

Jonathan M. Barnett, Have tech platforms captured the Supreme Court?, The Hill (Apr. 17, 2021)

Jonathan Barnett, Investors and Regulators Can Both Fall for Platform Bubbles, Truth on the Market (Mar. 2, 2021)

Jonathan Barnett, Why Big Tech Likes Weak IP, Cato Institute (Spring 2021)

CPIP Staff, CPIP First Quarter Progress Report (December 2020-February 2021), CPIP Blog (Mar. 31, 2021)

CPIP Staff, UC Hastings’ Evergreen Drug Patent Search Database: A Look Behind the Statistics Reveals Problems with this Approach to Identifying and Quantifying So-Called “Evergreening,” CPIP Blog (Mar. 4, 2021)

Wade Cribbs, Accenture Report Outlines How 5G Technology Accelerates Economic Growth, CPIP Blog (Mar. 8, 2021)

Wade Cribbs, Scalia Law’s Innovation Law Clinic Partners with BizLaunch for Online Legal Clinic on Business Entities for Startups, CPIP Blog (Mar. 10, 2021)

Tabrez Ebrahim, Professor Tabrez Ebrahim on Clean and Sustainable Technological Innovation, CPIP Blog (Mar. 25, 2021)

Christopher M. Holman, Branded Drug Companies Are Successfully Asserting the Doctrine of Equivalents in Hatch-Waxman Litigation, 40 Biotechnology Law Report 72 (Mar. 2021)

Mark David Janis and Ted M. Sichelman, Patent Law: An Open-Source Casebook (Chapter 5: Anticipation) (Apr. 26, 2021)

Mark David Janis, Ted M. Sichelman, John R. Allison, Thomas F. Cotter, Christopher Anthony Cotropia, Dmitry Karshtedt, Jeffrey A. Lefstin, Jason Rantanen, David Taylor and Shine (Sean) Tu, Patent Law: An Open-Source Casebook (Entire Book), UC Hastings Research Paper Forthcoming (May 6, 2021)

David J. Kappos and Jonathan Barnett, Covid-19 Vaccine Highlights the Need for Balanced Patent Policy, Bloomberg Law (Mar. 16, 2021)

Douglas C. Lippoldt and Mark F. Schultz, An Opportunity for Leadership on Trade Secrets Protection in the Australia-UK Free Trade Agreement, Institute for International Trade (Mar. 25, 2021)

Adam Mossoff and Devlin Hartline, Google v. Oracle: A Copyrightability Decision Masquerading as Fair Use, Washington Legal Foundation (May 7, 2021)

Christopher M. Newman, Isn’t Infringement Ever Apparent?: Toward a Balanced Reading of §512 of the Digital Millennium Copyright Act, George Mason Legal Studies Research Paper No. LS 21-03 (Mar. 5, 2021)

Kristen Osenga, If You’re Sailing Into the Headwinds, You Might Be Going In the Wrong Direction, RealClearMarkets (Apr. 20, 2021)

Kristen Osenga, Online Symposium: Prof. Osenga’s Top 2020 Federal Circuit Patent Decisions, FedCircuitBlog (Mar. 30, 2021)

Yogesh Pai, WTO IP waiver too simplistic: Global vaccine tech-transfer needs other strategies, CPIP Blog (Apr. 29, 2021) (Originally posted in the Express Pharma edition of the Indian Express, Apr. 28, 2021)

Jason Rantanen, Mark David Janis, and Ted M. Sichelman, Patent Law: An Open-Source Casebook (Chapter 7: Infringement) (Apr. 29, 2021)

Ryan Reynolds, Professors Balganesh and Menell on “The Curious Case of the Restatement of Copyright, CPIP Blog (Apr. 8, 2021)

Ryan Reynolds, Professor Justin Hughes on “Restating Copyright Law’s Originality Requirement, CPIP Blog (May 20, 2021)

Mark Schultz, The EU can put trust back into online commerce, The Brussels Times (Mar. 6, 2021)

Austin Shaffer, Artist Roundtable Presented by the Mason Sports & Entertainment Law Association and the Arts & Entertainment Advocacy Clinic, CPIP Blog (May 5, 2021)

Liz Velander, Ninth Circuit Narrows Copyright Owner’s Ability to Receive Multiple Statutory Damages Awards, CPIP Blog (Mar. 17, 2021)

Liz Velander, Recap of the Supreme Court’s Google v. Oracle Opinion,“ CPIP Blog (Apr. 23, 2021)

Categories
C-IP2 News

Happy Holidays from CPIP!

The CPIP Team sends you and yours our best wishes for a happy, safe holiday season and a Happy New Year!

Categories
C-IP2 News

#GivingTuesday: A Message from CPIP on Giving Tuesday 2020

CPIP logo

As we enter the holiday season and look ahead to 2021, we hope that you will keep CPIP in mind as you plan your end-of-year giving. Your support is critical to ensuring that CPIP can continue to bring reason and balance to the academic debate on intellectual property (IP) by engaging academics, creators, and innovators in a scholarly dialogue. Through our programs, events, network of scholars, and in-house staff, we have made great strides, but there is more work to be done. CPIP is an academic center and receives neither government funding nor funding from George Mason University, and it is only through the private support of our partners and sponsors that we can fulfill our mission.

To donate to CPIP, please visit: https://cip2.gmu.edu/donate-to-cpip/

You can also support CPIP by:

Your contributions help CPIP:

  • Host conferences, roundtables, fellowship meetings, symposia and colloquia, the WIPO Summer School on Intellectual Property, and many other programs that promote an ongoing dialogue on the importance of IP rights

  • Continue to build and maintain a community of research scholars and innovation industry stakeholders in the U.S.

  • Produce and support the production of a variety of cutting-edge research, scholarly articles, and policy materials that explore the value of IP and contribute to better-informed policy

  • Employ an in-house staff of directors and communications specialists who work tirelessly to plan and execute CPIP programs and events

  • Maintain and grow an international network of scholars, lawyers, and other professionals dedicated to the scholarly analysis of IP

Looking ahead to CPIP’s ninth year of operation, we are proud to be a leading academic voice in the discussion of IP rights and the technological, commercial, and creative innovation they facilitate. We have an exciting lineup of programs and events planned for 2021 as well as research and policy work agendas that will focus on key IP issues. The generosity of our partners and supporters is essential to CPIP’s success, and we thank you in advance for your support.

Categories
C-IP2 News Patent Law

CPIP 2020 Fall Conference: Day Two Recap

The following post comes from Wade Cribbs, a 2L at Scalia Law and a Research Assistant at CPIP. This is the second of two posts (see day one recap) summarizing our two-day 5G at the Nexus of IP, Antitrust, and Technology Leadership conference that was held online from George Mason University Antonin Scalia Law School on October 7-8, 2020.

By Wade Cribbs

On October 7-8, 2020, CPIP hosted its Eighth Annual Fall Conference, 5G at the Nexus of IP, Antitrust, and Technology Leadership, online from George Mason University Antonin Scalia Law School in Arlington, Virginia. The conference featured a keynote address by the Honorable Andrei Iancu, and it was co-hosted by Scalia Law’s National Security Institute (NSI).

This conference addressed fast-emerging intellectual property (IP), antitrust, and technology leadership issues in the 5G and “Internet of Things” innovation ecosystem. Coverage included standard-essential patents (SEPs) along with established and emerging markets on a regional and global basis. Speakers were drawn from the academic, industry, and policymaking communities, with an emphasis on using objective fact-based analysis to explore points of convergence among legal, economic, and geopolitical perspectives on the IP and regulatory infrastructures that underlie these critical industries.

SESSION 3: MARKETS WORK: PRIVATE ORDERING MECHANISMS IN PATENT-INTENSIVE MARKETS

The first panel of the day consisted of academics and industry experts discussing the path moving forward for intellectual property licensing and how it relates to 5G technology. CPIP Executive Director Sean O’Conner moderated the panel, directing a conversation on the mechanisms for controlling intellectual property licensing and the conflict between antitrust policy and private-ordering initiatives. Panelists included Prof. Jonathan Barnett of the University of Southern California, Dr. Bowman Heiden of the University of California, Berkeley, David Kappos of Cravath, Swain & Moore, and Luke McLeroy of Avanci.

Prof. Barnett opened the panel with a discussion of the difference between the theoretical models of IP licensing and the actual standard-essential patent market. According to the models, the burden of many standard-essential patents involved in developing a smartphone should cripple the smartphone market. Smartphones should cost thousands of dollars due only to the cost of royalties necessary for production. However, as Prof. Barnett pointed out, smartphones are more available than ever and at every price point. The empirical evidence confirms the theoretical models’ fears are inaccurate as the aggregate royalty burden is in the single digits.

Prof. Barnett went on to illustrate how this empirical evidence is shaping the DOJ Antitrust Division’s view of IP licensing. The fear has shifted from patent holdup, large patent royalties preventing innovation and competition, to a fear of patent holdout. Prof. Barnett explained that patent holdout is becoming common place in the market where a company’s most efficient method of obtaining an IP license is through litigation as opposed to negotiating a competitive licensing fee. Prof. Barnett concluded by suggesting that patent holdout occurs where property rights are not strong and clear. Where injunctive relief is awarded readily and aggressively to license owners, in the United Kingdom and Europe, patent holdout is not a prevalent issue.

Dr. Bowman framed the issue as an interplay between the public and private spheres. For the private sphere to produce, protection of its investment in the form of patents is necessary. The conflict is the public’s access to the private sector’s production is easily frustrated by a large number of standard-essential patents in an industry. Because access to the product is in the interest of the private sphere, the private sphere has solved its own problem. Industries require an agreement from a patent owner to license its patents on terms that are fair, reasonable, and non-discriminatory (FRAND). Without a FRAND agreement, a patent cannot be a standard-essential patent.

Dr. Bowman then examined the implementation of FRANDs in the wireless communication ecosystem. He argued that the inherent vagueness of FRANDs are a necessary feature as it allows for varied and customized solutions. Additionally, the public sphere, or other members of the private sphere, can obtain an advantage through antitrust authorities. However, innovation on the private side is always preferable to antitrust regulations.

Mr. Kappos began by emphasizing the need for balance between innovators and implementers. Current innovation-based standards create enormous consumer surplus, totaling nearly four trillion dollars in the wireless communication industry. He went on to say that innovation-based standards are far superior to previous proprietary, winner-take-all standards that produced limited consumer surplus.

Mr. Kappos further developed Prof. Barnett’s point about the need for injunctive relief to protect innovators. He highlighted that preliminary injunctive relief is available in other IP hubs, such as China and Germany, but that the United States has all but given up on awarding injunctive relief to innovators. In many cases, even when injunctive remedies are available, more is needed to compensate innovators for the lost opportunity, income, and effort. He then added that there needs to be a new recognition in license negotiations. Those who delay or try to avoid paying for licenses should be forced to pay a premium once they finally comply.

Mr. McLeroy discussed the nature of his licensing company Avanci. The company streamlines licensing of cellular standard-essential patents for internet connectivity in commercial products such as cars. It simplifies licensing by compacting all standard-essential licenses, from multiple patent owners, necessary for a product and offering them to companies in the industry at a flat rate. Avanci lowers the transaction costs by removing the time needed to identify the patents necessary and evaluate what the proper fee should be. This reduction in transaction costs allows the innovator to spend money that would have been spent on searching and negotiation back into research and development.

In response to a question, Mr. McLeroy discussed the way that 5G licensing will be administered. One potential method is based on usage. He compared a water meter intermittently transmitting data with autonomous cars constantly interacting with other vehicles and intersection equipment. The licensing fee for the water meter would be much lower than for the autonomous car due to the significantly lower scale of data transfer necessary to operate it.

All panelists agreed that strong and clear property rights in innovation are necessary for a productive global licensing market. Injunctive relief is also a necessary tool that must be made available to those developing innovative standard-essential patents.

SESSION 4: TECHNOLOGY LEADERSHIP IN 5G/IOT MARKETS

The second panel of the day focused on what steps should be taken to protect American leadership in the innovative technology sectors such as 5G networks. Moderator Jamil Jaffer, Founder & Executive Director of the National Security Institute (NSI), led the discussion on how the federal government can best handle the global development of 5G standards and protect American innovation from the competitive threat of China. Panelists included Megan Brown of Wiley Rain, Dr. Jonathan Putnam of Competition Dynamics, the Hon. Randall Rader of the Federal Circuit, and Andy Keiser of Navigators Global.

Dr. Putnam opened the discussion by addressing China’s patent program. Dr. Putnam described a model he created using research and development, gross national product, population, and other national indicators of inventive behavior. He noted that China subsidizes patent applications, resulting in the largest number of patents worldwide. Dr. Putnam addressed whether China has become the world leader in innovative technology. The model shows that while Chinese patent application numbers are dramatically increasing, the quality of those patents are notably lower than the rest of the world.

Dr. Putnam proposed three methods for the United States government to protect domestic interests without following the Chinese model of subsidizing innovators. First, the U.S. should unify its fractured view of antitrust on the global market. Presenting a common understanding of antitrust principles would remove a substantive fracture in U.S. foreign policy that works to China’s advantage. Second, the U.S. should take a more aggressive stance in enforcing fair trade on the world stage. There is systemic theft of foreign patent technology that must be curtailed. Third, in the pharmaceutical industry, private companies can take advantage of basic research conducted by the National Institute for Health. Applying this model to other technological sectors would be beneficial for American innovation as basic research is the foundation for most innovation.

Judge Rader agreed with Dr. Putnam that a large quantity of inferior patents is produced by China. However, Judge Rader distinguished the average patent seeker from the Chinese mega-corporations such as Huawei that produce innovation technology. Chinese mega-corporations are like American innovation leaders such as Qualcomm. Judge Rader explained that China built its platform out of subsidies in the past, but currently individual companies like Huawei devote large percentages of their gross budget to research and development that makes China a competitive innovator. China cannot be dismissed as a competitor built on unfair advantage. Instead, he urged, China must be confronted as an innovative equal that is willing to spend and supply the technology of the future.

Mr. Keiser identified China’s unique control over its market through tariffs, credit, and market manipulation. Unlike any other economy of similar size, its unique control positions China perfectly to advance its interests in innovation. Given that China is the United States’ biggest geopolitical competitor, China poses a serious threat to national security. Mr. Keiser pushed back against Judge Rader’s equal competitor view of China. He cited cases from both the United States and Poland where Huawei was found to have committed espionage and theft of competitors’ patents. Regardless of how China arrived at its current state, he said that Chinese 5G networks are not trustworthy due to consistent exploitation of foreign patents.

Ms. Brown voiced her concerns regarding the impulse to respond to China’s action by nationalizing 5G. She suggested optimizing regulation by removing the fragmented regime currently impeding innovation. The hands-off approach of Congress has facilitated longstanding U.S. leadership in innovation, and unprecedented congressional involvement would only harm American innovators. Ms. Brown framed Mr. Keiser’s point about the trustworthiness of Chinese 5G equipment and networks as a question of government intervention. Assuming these networks cannot be trusted, she asked how much the government should intervene to address the problem. In response to Dr. Putnam’s proposal of government-subsidized basic research, Ms. Brown argued that the focus should be real-world research and development with telecommunication carriers.

Ms. Brown warned that, specifically relating to 5G standard setting, the government must be careful to expend influence in its natural spheres. The 3rd Generation Partnership Project (3GPP) is a private sector, global body that leads the development of standards in 5G technology. As a global private sector organization, the federal government, in the form of the Department of Defense, has no business influencing 3GPP policy. If any government activity is warranted, she continued, it should incentivize more private American businesses to participate in and influence private organizations like 3GPP.

All the panelists agreed that the focus should be on American policy promoting domestic innovation as opposed to overreacting to the imposing threat of China. Foremost on policy makers minds must be preserving and promoting innovation from garage inventors to Qualcomm. However, Mr. Keiser stated that the scale of theft of intellectual property by China is too large to be ignored. Congressional protection in the form of laws such as the CHIPS Act, a bill to incentivize and subsidize research into semiconductors, is necessary.

CLOSING REMARKS

CPIP Executive Director Sean O’Connor and CPIP Deputy Director Joshua Kresh closed out the two-day conference by thanking all of the moderators, panelists, and attendees for making the conference such a huge success. They also thanked CPIP staff members, including Kristina Pietro, Devlin Hartline, and Mary Clare Durel, for working behind the scenes and the generous sponsors of the conference whose financial support made it possible.

Categories
C-IP2 News

CPIP Bids a Fond Farewell to Kevin Madigan and Seeks New Deputy Director

CPIP logoLongtime CPIP staff member Kevin Madigan is leaving the Center next week to become VP, Legal Policy and Copyright Counsel at the Copyright Alliance.

“I joined CPIP just over four years ago, and my time with the Center and Scalia Law has been rewarding on so many levels. The knowledge I’ve gained and the relationships I’ve cultivated are things that I’ll cherish for the rest of my life,” said Kevin Madigan. “I’m proud to have been a part of such a dynamic academic center, and I know CPIP will continue to thrive in my absence. I want to express my sincere gratitude to Sandra Aistars, Sean O’Connor, Adam Mossoff, Devlin Hartline, Matt Barblan, Mark Schultz, Kristina Pietro, and Mary Clare Durel,” he continued.

“We could not be happier for Kevin who has done impeccable work for us beginning as a Fellow and recently serving as Deputy Director. While we will miss him, we know that he will not be far away given our close relationship with CA,” said Sean O’Connor, Executive Director at CPIP.

As a result of Kevin’s departure, we are now seeking a new Deputy Director to join the CPIP team. This is an exciting position for an accomplished intellectual property professional seeking to advance their career at the interface of academia, industry, and public policy.

Reporting to CPIP’s faculty Executive Director, the Deputy Director manages and participates in CPIP’s day-to-day operations including academic and policy work as well as conferences, meetings, and other events. The Deputy Director also works with the Executive Director and other faculty directors to develop CPIP’s long-term academic and policy plans.

The position is designed for an individual with a J.D. degree and an interest in promoting innovation and creativity through CPIP’s academic and policy mission. The ideal candidate will have: strong experience in intellectual property law and policy; familiarity with the academic intellectual property community; and an understanding of government policy-making in Washington, D.C. and beyond. At least three years of IP law practice or IP policy experience are required.

The job listing is available at the following link: https://jobs.gmu.edu/postings/47630

Categories
Copyright

The CASE Act: Why Creators Need a Small Claims Tribunal


The Center for the Protection of Intellectual Property (CPIP) and the Intellectual Property Law Society (IPLS) at Antonin Scalia Law School, George Mason University, invite you to a panel discussion on the CASE Act.

2019 CASE Act panel flyer
Click on image for full-size PDF flyer.

The CASE Act: Why Creators Need a Small Claims Tribunal

Thursday
November 14, 2019
4:45 – 6:00 PM

Antonin Scalia Law School
George Mason University
3301 Fairfax Drive
Hazel Hall, Room 221
Arlington, Virginia

The event is free and open to the public. Please register in advance by emailing Kristina Pietro at kpietro@gmu.edu by 5:00 PM on Monday, November 11. Food will be provided.


EVENT DESCRIPTION

The Copyright Alternative Small-Claims Enforcement Act (CASE Act) would create a tribunal within the U.S. Copyright Office to hear small copyright claims. The federal courts have exclusive jurisdiction over copyright cases, and the cost of bringing a federal lawsuit makes it difficult for many individuals or small businesses to sue for copyright infringement. The CASE Act would provide a cheaper and simpler alternative to resolve such claims, allowing copyright owners to sue without the need to hire an attorney. The bill would also create a cost-effective way for users of copyrighted works to fight back when challenged if they believe their use is noninfringing.

The CASE Act has broad bipartisan support, and it was passed by the House in a sweeping 410-6 vote on October 22, 2019. The bill heads next to the Senate, where two Senators have placed a hold on the bill that will make it more difficult to pass. While many artist advocacy groups, such as Copyright Alliance, American Society of Media Photographers, and Authors Guild, have applauded the CASE Act’s provision of remedies for disenfranchised copyright owners, other groups, such as Electronic Frontier Foundation, Re:Create Coalition, and Public Knowledge, have condemned the bill as an assault on civil liberties that will potentially bankrupt average Americans.

This panel features three leading experts who have each played an important role in advocating for the CASE Act. They will discuss the substance and history of the CASE Act, its prospect for being passed by the Senate, and what it means for individuals and small businesses who have welcomed the meaningful copyright protection that the bill would provide.


EVENT AGENDA

4:45 – 5:00 PM Welcome Reception

5:00 – 6:00 PM Panel Discussion

  • Prof. Sandra Aistars, Antonin Scalia Law School, George Mason University, Director of Copyright Research and Policy & Senior Scholar, Center for the Protection of Intellectual Property
  • Terrica Carrington, Copyright Counsel, Copyright Alliance
  • Tom Kennedy, Executive Director, American Society of Media Photographers
  • Moderator: Prof. Devlin Hartline, Antonin Scalia Law School, George Mason University, Director of Communications, Center for the Protection of Intellectual Property

Categories
Copyright Innovation Patent Law

VIDEOS: Panel Presentations from the CPIP 2018 Fall Conference

2018 Fall Conference flyerOn October 11-12, 2018, CPIP hosted its Sixth Annual Fall Conference, IP for the Next Generation of Technology, at Antonin Scalia Law School, George Mason University, in Arlington, Virginia.

After the breakthrough technology that gave us the mobile technology revolution of the past fifteen years, another leap forward in technology is about to break out into consumer products and services. Our panelists addressed how IP rights and institutions can foster and support this technological advance and considered how IP helps creators, inventors, the creative industries, and the innovation industries move forward.

We are grateful for the panelists, moderators, and audience members who made our Sixth Annual Fall Conference such a huge success, and we hope you will enjoy the videos!


PANEL 1: NEW TECHNOLOGIES, BUSINESS MODELS, AND STANDARDS

  • Jim Harlan, Senior Director, Standards and Competition Policy, InterDigital
  • Anne Layne-Farrar, Vice President, Charles River Associates
  • Robert Sachs, President, Robert R. Sachs PC
  • Prof. Ted Sichelman, University of San Diego School of Law, Senior Scholar, Center for the Protection of Intellectual Property
  • Moderator: Prof. Kristen Osenga, University of Richmond School of Law, Senior Scholar, Center for the Protection of Intellectual Property

PANEL 2: NEW/SHIFTING BUSINESS MODELS FOR THE CREATIVE INDUSTRIES

  • Troy Dow, Vice President & Counsel, The Walt Disney Company
  • Prof. Eric Priest, University of Oregon School of Law, Senior Scholar, Center for the Protection of Intellectual Property
  • Jessica Richard, Vice President, Federal Public Policy, Recording Industry Association of America
  • Nicola Searle, Digital Economy Fellow & Senior Lecturer, Goldsmiths, University of London
  • Moderator: Prof. Sandra Aistars, Antonin Scalia Law School, George Mason University, Director of Copyright Research and Policy & Senior Scholar, Center for the Protection of Intellectual Property

PANEL 3: NEW/SHIFTING BUSINESS MODELS FOR THE INNOVATION INDUSTRIES

  • Prof. Jonathan Barnett, USC Gould School of Law, Senior Scholar, Center for the Protection of Intellectual Property
  • Henry Hadad, Senior Vice President & Deputy General Counsel, Bristol-Myers Squibb
  • Prof. Erika Lietzan, University of Missouri School of Law, Senior Scholar, Center for the Protection of Intellectual Property
  • Jake Mace, Vice President of Licensing, Dominion Harbor
  • Moderator: Prof. Christopher Holman, University of Missouri-Kansas City School of Law, Senior Scholar, Center for the Protection of Intellectual Property

PANEL 4: A DIFFERENT PERSPECTIVE ON BIG DATA

  • Prof. Ryan Abbott, School of Law, University of Surrey
  • Robert Atkinson, Founder & President, Information Technology and Innovation Foundation
  • Prof. Michael Smith, Heinz College, Carnegie Mellon University
  • Marian Underweiser, Senior Counsel, IBM Research
  • Moderator: Prof. Robert Ledig, Antonin Scalia Law School, George Mason University

PANEL 5: THE FUTURE OF STANDARD SETTING, 5G, AND WHERE IT’S ALL HEADED

  • Kirti Gupta, Senior Director of Economic Strategy, Qualcomm
  • Prof. Adam Mossoff, Antonin Scalia Law School, George Mason University, Founder, Executive Director, & Senior Scholar, Center for the Protection of Intellectual Property
  • Richard Taffet, Partner, Morgan Lewis & Bockius LLP
  • Gregory Werden, Senior Economic Counsel, Antitrust Division, U.S. Department of Justice
  • Moderator: Prof. Sean O’Connor, Antonin Scalia Law School, George Mason University, Director of International Innovation Policy & Senior Scholar, Center for the Protection of Intellectual Property

PANEL 6: THE HISTORY OF IP AND TECHNOLOGICAL SHIFTS: LESSONS FROM THE ANCIENT HISTORY OF THE 1990S AND BEFORE

  • Prof. Bruce Boyden, Marquette University Law School
  • Prof. Joseph Gabriel, Florida State University College of Medicine
  • Prof. Justin Hughes, Loyola Law School, Los Angeles
  • Ron Katznelson, Founder & President, Bi-Level Technologies
  • Moderator: Prof. Ross Davies, Antonin Scalia Law School, George Mason University

Categories
Press Release

CPIP Announces Leadership Transitions

CPIP logoARLINGTON, Virginia – August 22, 2018 – The Center for the Protection of Intellectual Property (CPIP) announced today that Matthew Barblan, CPIP’s Executive Director, will leave the center this month to join the Association of American Publishers (AAP) as Vice President, Public Policy. “It has been an amazing journey working with such wonderful colleagues to build CPIP from the ground up over the past five years,” said Barblan. “I’m deeply grateful to my friends at CPIP and Scalia Law for making the center’s success possible, and I look forward to following CPIP’s growth and influence for years to come.”

Beginning on August 27, 2018, CPIP founder Adam Mossoff will become Executive Director of the center. “As a founding member of CPIP’s leadership team, Matt was absolutely essential to the success of the center over the last five years,” said Mossoff. “I will miss very much my day-to-day interactions with Matt at Scalia Law, but I’m looking forward to continuing to engage with him at future CPIP events on IP policy in his new role in representing the publishing industry.”

As part of the transition, longtime CPIP friend and senior scholar Sean O’Connor has joined CPIP as Director of International Innovation Policy. O’Connor will be an integral part of CPIP’s leadership team, focusing on law and policy issues regarding innovation and entrepreneurship, with a particular focus on international contexts.

“I’m excited about the future of CPIP, and it is a great pleasure to welcome Sean to the team,” said Henry N. Butler, Dean of Antonin Scalia Law School. “On behalf of the Scalia Law community, I also want to thank Matt for everything he has done over the past five years to take CPIP from idea to reality and build it into the successful center that it is today. Matt has been a great colleague and friend to the law school, and we wish him all the best in his new role at AAP.”

About the Center for the Protection of Intellectual Property

The Center for the Protection of Intellectual Property (CPIP) at Antonin Scalia Law School is dedicated to the scholarly analysis of intellectual property rights and the technological, commercial, and creative innovation they facilitate.

CONTACT:
Devlin Hartline
jhartli2@gmu.edu
703-993-8086

Categories
Innovate4Health

Innovate4Health: Nutriset Uses Patents and Trademarks to Fight Severe Malnutrition Across the Globe

This post is one of a series in the #Innovate4Health policy research initiative.

Innovate4HealthBy Nick Churchill

Malnutrition is one of the greatest global health challenges, particularly with regard to children and pregnant women in developing countries. Undernutrition contributes to nearly half of all deaths among children under the age of 5 and has lifelong consequences for physical and cognitive wellbeing.

Nutriset has confronted the global malnutrition problem head-on by developing a range of innovative nutritional products and using its intellectual property to help developing countries reach nutritional autonomy.

Malnutrition is a blanket term that includes both undernutrition and micronutrient deficiency. An estimated 11 percent of the world’s population, or 815 million people, are undernourished. Undernourished people are particularly vulnerable to disease and death, and both undernutrition and deficiencies in micronutrients can prevent proper growth and development. Undernutrition causes children to underperform in school and makes adults less able to work, perpetuating a cycle of poverty. It can also be deadly. Children suffering from severe acute malnutrition, characterized by very low weight and visible muscle wasting, require urgent treatment to survive.

Severely undernourished patients have traditionally been treated with powdered foods which are dissolved in water before consumption. These powdered products carry risks of dosage errors and bacterial contamination, and they are likely to cause diarrhea in undernourished patients. They also tend to have short shelf lives, particularly in tropical climates.

Nutriset was founded in 1986 by Michel Lescanne with the mission of “focusing on research in the field of humanitarian nutrition, developing innovative solutions and acting as an interface between the worlds of humanitarian aid, nutritionists and food industry technologies.” Since then, Nutriset has developed several therapeutic milks, pastes, and tablets. In 1996, Nutriset partnered with Dr. Andre Briend to create Plumpy’Nut®, the first ready-to-use therapeutic food (or, RUTF) for the treatment of severe acute malnutrition.

This new product was field tested in Malawi by Dr. Mark Manary, who discovered that RUTFs were much more effective than traditional treatments. Dr. Manary was able to clear his hospital’s malnutrition ward and use RUTFs to treat his patients at their homes, while increasing the recovery rate from 25% to 95%. Given the product’s success, Dr. Manary recognized the long-term impact RUTFs could have if they were manufactured in the countries that needed them. Together, the doctors simplified the recipe so it could be produced locally.

A woman and child sitting on a bend next to a box. The woman is giving the child something to drink.Plumpy’Nut® has a long, 2-year shelf-life, is formulated to avoid diarrhea-type side effects, and can be eaten right out of the packet, eliminating the risks of dosage errors and contamination associated with mixing a powder with water. Plumpy’Nut®’s long shelf-life, effectiveness, and ease-of-use have led to a rise in community-based treatment of acute malnutrition and have made it possible to treat children in areas that were not reached by traditional methods.

Nutriset has used its patent rights to further increase access to its technologies in developing countries through its PlumpyField® network. Nutriset partners with local entrepreneurs in franchise-like relationships to create sustainable production systems in developing countries. In addition to benefiting from Nutriset’s reputation and manufacturing experience, network partners are given access to Nutriset’s patents and trademarks. The franchise-like system based on granting rights to use its intellectual property allows Nutriset to ensure that all products being locally produced by network members embody the innovations that actually help those suffering from malnutrition. And by supporting the local manufacture of its innovative products, Nutriset enables its partners to provide jobs to local people, source raw materials from local farmers, and customize the products to address the specific nutritional needs of their communities, while decreasing dependency on foreign organizations.

The PlumpyField® network consists of 9 members based in Central America, Africa, Asia, Europe, and the U.S. While the majority of the products are still manufactured in France and the U.S., members in developing countries continue to increase their production capacity, bringing the network’s total capacity to 117,400 metric tons. In 2016, the network’s products were used to treat nearly 8 million children. Thanks to Nutriset’s focus on incentivizing local capacity, that number will surely rise. According to the United Nation’s Food and Agriculture Organization, increasing local production is one of the best ways of ensuring long-term food security. Nutriset’s success in this endeavor would not be possible without its intellectual property rights.

The story of Plumpy’Nut® and PlumpyField® illustrates the power of intellectual property rights to improve and save lives. Not only do IP rights encourage the development of innovative products, they can be used to implement sustainable solutions to some of the world’s most pressing health challenges.

#Innovate4Health is a joint research project by the Center for the Protection of Intellectual Property (CPIP) and the Information Technology & Innovation Foundation (ITIF). This project highlights how intellectual property-driven innovation can address global health challenges. If you have questions, comments, or a suggestion for a story we should highlight, we’d love to hear from you. Please contact Devlin Hartline at jhartli2@gmu.edu.

Categories
Innovate4Health Innovation Patents

Innovate4Health: Treating Neonatal Jaundice in the Developing World with D-Rev’s Brilliance

This post is one of a series in the #Innovate4Health policy research initiative.

Innovate4HealthBy Nick Churchill

Severe neonatal jaundice kills over 100,000 newborn babies annually and causes severe brain damage to thousands more. In most cases, the condition can be treated by simply shining a blue light on a baby’s skin. However, each year more than 6 million infants worldwide do not receive adequate treatment. The problem is particularly severe in low-income countries, where many hospitals cannot afford the equipment to treat jaundice.

To address this global health problem, the innovators at D-Rev, a non-profit firm based in San Francisco, designed a high-performance, affordable device called Brilliance to treat severe neonatal jaundice. Brilliance has been praised by users as “effective and user-friendly,” and it was honored as the top innovation in the Health category of the 2016 Tech Awards. Since the introduction of the first Brilliance model in 2012, D-Rev estimates that the device has treated over 250,000 babies and has averted approximately 3,400 infant deaths and disabilities.

Neonatal jaundice occurs when a newborn has elevated levels of bilirubin in the blood. Approximately 18% of babies have severely high levels of bilirubin, which, left untreated, can lead to brain damage, cerebral palsy, hearing loss, and even death. Severe jaundice can be treated with a process called phototherapy, which involves placing the baby under special blue lights. When the light is absorbed by the infant’s skin, it helps break down bilirubin. Treated properly, severe jaundice usually does not cause lasting damage.

Phototherapy has long been recognized as a simple and effective treatment for severe neonatal jaundice; but at around $3,000, traditional phototherapy devices are prohibitively expensive for many hospitals in developing countries. Hospitals that can obtain a traditional unit are often unable to afford the maintenance and repair costs necessary to keep it running. The unreliable electrical systems in many developing countries can cause voltage spikes that damage device components. Commonly used fluorescent lamps require frequent replacement. As a result, phototherapy is unavailable to babies in many developing communities.

D-Rev is a product development company founded in 2007 to provide world-class, affordable healthcare technologies to people living on very low incomes. After learning that severe jaundice continues to cause brain damage in many parts of the world, D-Rev staff members visited hospitals in India and Nigeria to assess the availability of effective phototherapy and found that most of these hospitals did not have phototherapy devices that met standards for care. With the problem identified, D-Rev’s design team got to work.

D-Rev’s advanced devices, for which they are seeking a patent, uses LEDs that last 60x longer than fluorescent lamps, saving hospitals over $240 per year on replacement bulbs. Brilliance is designed to withstand a range of power fluctuations without affecting performance and operates without cooling fans or filters, so there are fewer parts to maintain. The device is height-adjustable and can be integrated with the wide variety of other critical neonatal medical equipment found in hospitals serving low-income communities.

Importantly, D-Rev’s devices are inexpensive to manufacture, which allows D-Rev to sell them for hundreds, instead of thousands, of dollars. The newest model incorporates the technology in their patent application, which ensures light intensity levels remain consistent across the treatment area at any angle of tilt. D-Rev also developed an integrated light meter to help healthcare providers ensure that infants receive appropriate doses of light, something many low income hospitals were previously unable to do. Thus, the innovations developed by D-Rev are improving the technology and reducing cost, making much needed treatments more accessible in the developing world.

After successfully designing an affordable and effective phototherapy device, D-Rev’s next challenge was to find a way to deliver Brilliance to the hospitals that needed it most. D-Rev’s CEO, Krista Donaldson, recognized that the firm would need help to establish a sales and distribution network, noting, “We knew we needed to license in this case.” To achieve its goals, D-Rev needed to find a partner willing to manufacture its products and distribute them to hospitals and clinics in the poorest communities in the world.

D-Rev licensed its technology to Phoenix Medical Systems, a neonatal equipment firm based in India, who agreed to manufacture and distribute Brilliance while capping its price. The licensing agreement was structured so that D-Rev would take a smaller royalty on sales to public and district hospitals, which tend to serve lower-income patients. In this way, D-Rev used its intellectual property rights to align the incentives of Phoenix’s sales team with D-Rev’s goal of reaching those patients who are most in need of affordable phototherapy.

Donaldson has explained why D-Rev’s protection of its intellectual property “is a prerequisite to having the broadest possible impact.” First, intellectual property rights allow D-Rev to ensure that the quality of its products remains consistent. As Donaldson notes, a medical device “cannot fail the user, particularly a user in a vulnerable population.” Second, inconsistency erodes consumer trust, which limits the impact of a product. Third, D-Rev recognizes that designing an effective product does not necessarily solve the targeted problem. By retaining control of its intellectual property, D-Rev can ensure consistent manufacturing of its products, sustainable delivery to users who need it, and continued maintenance and support. Finally, D-Rev protects its intellectual property because the market is “the most economically sustainable and scalable way” of reaching their intended customers.

D-Rev has demonstrated that the value of intellectual property goes beyond incentivizing life-saving innovation like Brilliance. Intellectual property rights empower innovators to increase their impact by partnering with market leaders like Phoenix. As Donaldson concluded: “To succeed, serious partners (for-profit or non-profit) must also make an investment, and none are willing to do that with the threat of knock-offs.”

#Innovate4Health is a joint research project by the Center for the Protection of Intellectual Property (CPIP) and the Information Technology & Innovation Foundation (ITIF). This project highlights how intellectual property-driven innovation can address global health challenges. If you have questions, comments, or a suggestion for a story we should highlight, we’d love to hear from you. Please contact Devlin Hartline at jhartli2@gmu.edu.